5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.36▼ | 2.37▼ | 2.38▼ | 2.39▼ | 2.35▼ |
MA10 | 2.38▼ | 2.39▼ | 2.39▼ | 2.35▼ | 2.51▼ |
MA20 | 2.39▼ | 2.39▼ | 2.41▼ | 2.35▼ | 2.42▼ |
MA50 | 2.42▼ | 2.41▼ | 2.38▼ | 2.57▼ | 3.65▼ |
MA100 | 2.41▼ | 2.36▼ | 2.36▼ | 2.40▼ | 6.54▼ |
MA200 | 2.37▼ | 2.37▼ | 2.49▼ | 2.86▼ | 10.08▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | -0.006▼ | -0.009▼ | 0.013▲ | 0.105▲ |
RSI | 39.893▼ | 38.724▼ | 39.916▼ | 43.696▼ | 44.321▼ |
STOCH | 25.794 | 46.548 | 58.770 | 62.474 | 29.034 |
WILL %R | -85.000▼ | -85.000▼ | -88.462▼ | -64.516 | -76.106▼ |
CCI | -121.253▼ | -152.056▼ | -153.032▼ | 21.538 | -69.499 |
Tuesday, September 16, 2025 04:50 AM
The original anhydrous form of buntanetap has been used in all preclinical and clinical studies to date. Recently, the Annovis team identified a new dihydrate crystal, which incorporates two moles of ...
|
Monday, September 15, 2025 06:07 AM
Novartis AG (NYSE:NVS) is one of the best defensive stocks to buy, according to Steve Cohen. On September 9, the company confirmed plans to acquire the New York-based pharmaceutical company Tourmaline ...
|
Monday, September 08, 2025 11:13 PM
Novartis (NYSE:NVS) to acquire Tourmaline Bio (NASDAQ:TRML) for $48.00 per share in cash, or a total equity value of approximately $1.4 billion, the companies said on Tuesday. The deal underscores the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 2.40 | 2.43 | 2.32 | 2.32 | 78,900 |
16/09/25 | 2.33 | 2.44 | 2.33 | 2.37 | 111,400 |
15/09/25 | 2.45 | 2.47 | 2.37 | 2.39 | 138,593 |
12/09/25 | 2.40 | 2.52 | 2.36 | 2.48 | 313,200 |
11/09/25 | 2.38 | 2.40 | 2.34 | 2.39 | 199,700 |
10/09/25 | 2.36 | 2.40 | 2.26 | 2.31 | 170,100 |
09/09/25 | 2.36 | 2.39 | 2.31 | 2.36 | 229,300 |
08/09/25 | 2.30 | 2.35 | 2.26 | 2.35 | 265,800 |
05/09/25 | 2.32 | 2.34 | 2.22 | 2.29 | 169,300 |
04/09/25 | 2.28 | 2.295 | 2.21 | 2.28 | 128,882 |
|
|
||||
|
|
||||
|
|